Skip to content

Recovery After Fast Track THA / TKA

Prospective Descripive Study of Subacute Function After Total Hip or Knee Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02137655
Acronym
0-21
Enrollment
112
Registered
2014-05-14
Start date
2014-05-31
Completion date
2016-02-29
Last updated
2016-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip and Knee Osteoarthritis

Brief summary

The development and implementation of fast-track principles in total knee and hip arthroplasty have resulted in early recovery and rehabilitation alongside a reduced length of hospital stay. This without a concomitant increase in morbidity or readmissions for medical or surgical complications and with reduced mortality. However, only little is known about function in the subacute period after arthroplasty, and there is a need for further data on physical and psychological functioning following discharge from hospital.This to ensure, that the positive results from the perioperative setting are carried forward in the subacute phase.

Detailed description

Data will be published in three papers: 1. Physical function and related factors following discharge from THA and TKA Luna IE, Kehlet H, Aasvang EK. 2. Postoperative hypoxemia following fast-track hip and knee arthroplasty Luna IE, Kehlet H, Aasvang EK. 3. Cognitive dysfunction after fast-track hip- and knee arthroplasty - prevalence and related factors. Luna IE, Kehlet H, Aasvang EK.

Interventions

None listed

Sponsors

Lundbeck Foundation
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Primary total hip or knee arthroplasty * Age 55 to 80 years

Exclusion criteria

* Deficient written or spoken danish * Alcohol abuse (\>21 U per week) * Immunocompromised * Anticoagulant therapy * ASA class 4-5 * Functional impairment from psychological or neurological disease * Sleepapnea

Design outcomes

Primary

MeasureTime frameDescription
Pain48 hours postoperativelyVAS when walking

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026